Skip to main content

Table 2 Frequent genetic aberrations in osteosarcoma

From: Establishment of a patient-derived orthotopic osteosarcoma mouse model

Gene locus (locus name)

Human tissue OS-RH-2011

Orthotopic mouse tumor P3

Subcutaneous mouse tumor P3

Primary cell cultureP3*

1p22.3 (BCL10)

Gain / amplification

Gain / amplification

No variation

Gain / amplification

3q13.31 (LSAMP)

LOH / Del

LOH / Del

No variation

LOH / Del

3p26.1 (SUMF1)

No variation

No variation

LOH / Del

No variation

6p21.1 (RUNX2)

Gain / amplification

Gain / amplification

No variation

Gain / amplification

7q31.33 (POT1)

Gain / amplification

Gain / amplification

No variation

Gain / amplification

8q24.21 (Myc)

Gain / amplification

Gain / amplification

Gain / amplification

Gain / amplification

13q14 (RB1)

LOH / Del

LOH / Del

LOH / Del

LOH / Del

17p13.1 (TP53)

Gain / amplification

Gain / amplification

No variation

Gain / amplification

17q25.1 (SLC25A19)

Gain / amplification

Gain / amplification

No variation

Gain / amplification

19q13 (GLTSCR1)

Gain / amplification

Gain / amplification

No variation

Gain / amplification

  1. Loss of heterozygocity (LOH) was defined as log2 ratio per clone > − 0.25, Amplification was defined as log2 ratio per clone > 0.25.